(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 2.07% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.61%.
Baxter International's revenue in 2025 is $11,023,000,000.On average, 19 Wall Street analysts forecast BAX's revenue for 2025 to be $5,751,770,402,145, with the lowest BAX revenue forecast at $5,514,276,620,235, and the highest BAX revenue forecast at $6,018,051,309,135. On average, 19 Wall Street analysts forecast BAX's revenue for 2026 to be $5,867,947,014,075, with the lowest BAX revenue forecast at $5,599,095,828,060, and the highest BAX revenue forecast at $6,214,934,682,450.
In 2027, BAX is forecast to generate $6,033,987,039,090 in revenue, with the lowest revenue forecast at $5,611,433,167,380 and the highest revenue forecast at $6,400,508,828,055.